130
Participants
Start Date
November 1, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
August 1, 2026
Travesol 10%
Travesol 10% (Baxter) will be administered to the post-intervention participants at a dose of 2g per kilogram of ideal body weight for up to 3 days or until the participant's discharge from the intensive care unit.
Milton S. Hershey Medical Center
OTHER